Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
about
Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Inactivated influenza virus vaccines: the future of TIV and QIV.Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.Signaling by Antibodies: Recent Progress.Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody.Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge ModelAlveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.Influenza: A broadly protective antibody.Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory StudyInduction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical TrialAsymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capThe Role of Fc Gamma Receptors in Broad Protection against Influenza VirusesNucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
P2860
Q30400230-CDDC63C8-2BDB-4AD3-81F7-499D74C1FD14Q38683726-FF68E60D-013A-4693-BCBB-2D3ABFE8427AQ38868293-824954F4-B00E-49ED-80A9-B73525B4D69DQ39264890-C52C489D-56C1-48BE-8CF7-BCC70961AAD8Q40041335-F0B313A1-D729-4394-BD6C-28767A0C3578Q40056879-055E3912-79FA-46DD-A8A6-F98D067EFE01Q40075978-7F03A777-22CD-47D4-A2D4-A6DABC93CF3BQ40279321-8D8B43CB-B5B4-4799-B0A0-61557774E747Q41676246-02B4D8E8-E5D9-4643-BA2E-CD5D68135349Q41919718-99F3D785-FB1D-4B26-A50C-A0993D415C5BQ47550457-A6B5068D-904F-4C9A-BEA4-D956DCF7D0C9Q47558906-0D5DAE0B-C5B7-4959-A267-C05C2F3600CCQ47608146-DFA08E0B-B8DA-4EA5-BCCA-B67137F04C35Q49965879-E735F918-421A-4E9A-AA3B-5F81C7BA75B1Q50140660-91D766FF-6A33-466B-AA1B-4358F3029DE8Q52609074-1C0F24F0-A10A-461B-A0AC-D1F919402FD7Q55260817-EE1FF5F4-4C14-4B42-9C34-22E207846343Q55501368-DB14C66D-3665-4A02-89AB-503F1E893AE7Q55689231-FA0A2BD2-07AE-495F-86E3-D6D2D85A1C69Q56535761-B3DA5A58-622F-4C9E-B70B-D3E0D9582C6EQ56562454-113506FF-02CF-4C0E-9519-BEE121205CC6Q56999931-82C30E22-EA2D-4D25-A089-DAAA2BE96257Q57019841-4FA8B2E1-7226-46CA-A419-458AFFB82985Q58721961-2E243047-9529-434F-B355-29C90425FD0E
P2860
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimal activation of Fc-media ...... equires two points of contact.
@en
Optimal activation of Fc-media ...... equires two points of contact.
@nl
type
label
Optimal activation of Fc-media ...... equires two points of contact.
@en
Optimal activation of Fc-media ...... equires two points of contact.
@nl
prefLabel
Optimal activation of Fc-media ...... equires two points of contact.
@en
Optimal activation of Fc-media ...... equires two points of contact.
@nl
P2093
P2860
P50
P356
P1476
Optimal activation of Fc-media ...... equires two points of contact.
@en
P2093
Caitlin E Mullarkey
Gene S Tan
Paul E Leon
Wenqian He
P2860
P304
E5944-E5951
P356
10.1073/PNAS.1613225113
P407
P577
2016-09-19T00:00:00Z